Abstract : Purpose : Nicorandil opens adenosine triphosphate-sensitive potassium (KATP) channels in the cardiovascular system and is being increasingly used for the treatment of angina pectoris. In the present study, we tested whether intravenous anesthetic agent ketamine affected nicorandil-induced native vascular KATP channel activation. Methods : We used excised inside-out patch clamp configurations to investigate the direct effects of ketamine racemate and S-(+)-ketamine on the activities of KATP channels in cultured rat aortic smooth muscle cells. Furthermore, we also investigated whether intracellular MgADP could modulate ketamine inhibition. Results : Nicorandil significantly activated KATP channel activity, whereas this channel activity was completely blocked by glibenclamide, a specific KATP channel blocker. Ketamine racemate inhibited the nicorandil induced KATP channel activity (IC50=34 1 !M, n=14), but S-(+)-ketamine was less potent than ketamine racemate in blocking nicorandil induced KATP channel activities (IC50=226 7 !M, 
INTRODUCTION
Adenosine triphosphate-sensitive potassium (KATP) channels are widely distributed in various tissues, and respond to changes in the cell metabolism (1) . In vascular smooth muscle cells, the opening of KATP channels causes vasodilation under physiological and pathophysiological conditions (2) .
Nicorandil is a KATP channel opener with nitratelike properties used in the management of angina pectoris (3, 4) . Furthermore, a recent prospective randomized multicenter study demonstrated that prophylactic administration of nicorandil during operation reduced the frequency of cardiac events in patients undergoing noncardiac surgery (5) . However, our previous studies have indicated that intravenous anesthetics, including ketamine directly inhibited KATP channel activities (6 -8) . Thus, it is
ORIGINAL
Effects of ketamine on nicorandil induced ATP-sensitive potassium channel activity in cell line derived from rat aortic smooth muscle important to understand whether significant interactions might occur between nicorandil and intravenous anesthetics when both drugs are administrated concurrently. KATP channels are regulated by changes in intracellular ATP and ADP concentrations (1) . Previous studies on native KATP channels have suggested that nicorandil action is also dependent on the presence of MgADP (9, 10) . But whether the action of ketamine on nicorandil induced KATP channels depends on the presence of MgADP is currently unknown.
In the current study, we used patch clamp techniques to examine the electrophysiological effects of ketamine on nicorandil induced KATP channel activity in cultured rat aortic smooth muscle cells. We also determined the effects of intracellular MgADP on ketamine action.
MATERIALS AND METHODS

Cell culture
A continuous line of A10 vascular smooth muscle cells, derived from the thoracic aorta of fetal rats, was obtained from the American Type Culture Collection (ATCC). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (Life Technologies, Invitrogen, Carlsbad, CA, USA), 3.7 mg ml -1 NaHCO3, and 100 μg ml -1 gentamycin at 37" $in a humidified atmosphere of 95% air and 5% CO2. The medium was changed initially after 48 h and then every 2-3 days. When the cells had formed a confluent monolayer after 7-9 days, they were rendered quiescent by incubation in serum -free medium for 24 h and then harvested by the addition of 0.05% trypsin and 0.1% fetal bovine serum. Cells were used for experiment after 12 passages.
Electrophysiological analysis
Channel currents were recorded with a patch clamp amplifier (CEZ 2200 ; Nihon Kohden, Tokyo, Japan) and stored in a personal computer (Aptiva ; International Business Machine Corporation, Armonk, NY, USA) with an analogue-to-digital converter (DigiData 1200 ; Axon Instruments, Foster City, CA, USA). pClamp version 7 software (Axon Instruments, Foster City, CA, USA) was used for data acquisition and analysis.
Electrophysiological measurements
Single channel currents were recorded in the inside-out configurations using a patch clamp amplifier as described previously (6) (7) (8) . The intracellular solution contained 140 mM KCl, 2 mM EGTA, 2 mM MgCl2, and 10 mM HEPES (pH=7.3). The pipette solution contained 140 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES (pH=7.4). Patch pipettes were pulled with an electrode puller (PP-830 ; Narishige, Tokyo, Japan). Recordings were made at 36#0.5" $. The resistance of pipettes filled with internal solution and immersed in Tyrode's solution was 5-7 MΩ. The sampling frequency of the single-channel data was 5 KHz with a low-pass filter (1 KHz) . The open probability (Po) was determined from current amplitude histograms and was calculated as follows :
where tj is the time spent at current levels corresponding to j=0, 1, 2, N channels in the open state ; Td is the duration of the recording ; and N is the number of the channels active in the patch. Recordings of 1-2 min were analyzed to determine Po. The channel activity was expressed as NPo. The NPo in the presence of drugs was normalized to the baseline NPo value obtained before drug administration and presented as relative channel activity.
Superfusates were directly applied to cells in the glass-bottom plastic cell bath (2-ml volume) at a rate of 2-2.5 ml/min using a plastic syringe (50-ml volume), vinyl chloride tubing (0.8-mm ID ; 50-cm length), and syringe pump (Terumo STC-525 ; Tokyo, Japan). When the concentration-dependent effects of drugs were studied, the superfusion was stopped for approximately 1 min at each concentration, and these drugs were injected into the cell bath using a glass syringe to five final concentrations in a cumulative manner (total volume injected was approximately 10-20 μl). Thus, the superfusion was stopped for total of approximately 5 min, and preliminary studies showed that stopping superfusion for approximately 5 min had no significant effects on electrophysiological measurements. The drug concentration needed to induce half-maximal inhibition of the channels (IC50) and the Hill coefficients were calculated as follows :
where y is the relative NPo, [D] is the concentration of drug, Ki is the IC50, and H is the Hill coefficient.
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Statistics
All data are presented as means!SE. Repeatedmeasures analysis of variance, followed by the Student-Newman-Keuls test, was applied to identify significant differences among the effects observed with different concentrations of ketamine racemate or S-(+)-ketamine. Paired statistical comparisons were made using paired t tests. In all comparisons, P!0.05 was considered significant.
Drugs
Ketamine racemate, S-(+)-ketamine, glibenclamide, and nicorandil were obtained from SigmaAldrich Japan (Tokyo, Japan). Glibenclamide and nicorandil were dissolved in dimethylsulfoxide (DMSO, the final concentration of solvent in the cell bath was 0.01%). Preliminary studies showed that 0.02% of DMSO, a 2-fold higher concentration than used in the present study, had no significant effects on cultured rat aortic smooth muscle KATP channel currents.
RESULTS
Nicorandil induced KATP channel activities in A10 cell derived from rat aortic smooth muscle
The effects of nicorandil on KATP channel in inside-out patch clamp configuration were recorded ( Figure 1A ). Single channel activities were observed infrequently before treatment of nicorandil (NPo! 0.001, n=10). Application of 100 μM nicorandil to the bath solution (intracellular side) significantly activated K + -selective channel activities. These channel activities were completely blocked by 0.5 μM glibenclamide, a specific KATP channel inhibitor ( Figure 1A,  n=10) , suggesting that the activity is indeed due to KATP channel currents. Figure 1B 
Effects of ketamine racemate on nicorandil induced KATP channel activities
To assess the effects of ketamine on nicorandil induced KATP channel activities in the absence of intracellular ADP, we measured single channel currents on inside-out patches in the presence of ketamine racemate. Application of 1-1000 μM ketamine racemate to the intracellular membrane surface inhibited the nicorandil induced KATP channel currents in a dose dependent-manner. As indicated in Figure  3A the inhibitory effects of ketamine racemate on KATP channel activities were readily reversible.
The dose-dependent effects of ketamine racemate on nicorandil induced KATP channel activities in the absence of intracellular ADP are shown in Figure  3B . The IC50 and Hill coefficient (h) of ketamine racemate for the KATP channels are 34!1 μM and 0.93 (n=14), respectively. The average percent recovery of KATP channel activities after washout of ketamine racemate was 92!2% of the NPo measured before drug treatment.
Effects of S-(+)-ketamine on nicorandil induced KATP channel activities
In contrast to ketamine racemate, S-(+)-ketamine at 1-30 μM did not significantly inhibit nicorandil induced KATP channel currents ( Figure 4A, n=11) , indicating that the inhibitory effect of ketamine on nicorandil induced KATP channel activities may be stereoselective.
The dose-dependent effects of S-(+)-ketamine on nicorandil induced KATP channel activities in the absence of intracellular ADP are shown in Figure 4B . The IC50 and Hill coefficient (h) of S-(+)-ketamine for the nicorandil induced KATP channels are 226!7 μM and 1.01 (n=10), respectively. The average percent recovery of KATP channel activities after washout of S-(+)-ketamine was 94!3% of the NPo measured before drug treatment.
Effects of ketamine racemate on nicorandil induced KATP channel activities in the presence of intracellular ADP
Recent studies have demonstrated that the effects of KATP channel agonists (9, 10) and ketamine racemate (8) on KATP channels are modified by interaction of MgADP with sulphonylurea receptors (SURs). Therefore, we next examined whether the inhibitory effects of ketamine racemate on nicorandil induced KATP channel currents in rat aortic smooth muscle cells are affected by the presence of intracellular MgADP. Figure 5A and 5B shows the effects of 30 μM ketamine racemate on nicorandil induced KATP channel activities in the absence or presence of a physiological concentration of MgADP (100 μM). Application of MgADP to the intracellular side of the channels significantly reduced the ketamine racemate inhibition of nicorandil induced KATP channel activities. In addition, the inhibitory potency of ketamine racemate on nicorandil induced KATP channel activities was attenuated in the presence of intracellular MgADP ( Figure 6A and 6B) ; ketamine racemate significantly inhibited nicorandil induced KATP channel activities only at the highest concentration (1000 μM, n=8, p!0.05 vs. baseline).
DISCUSSION
In the present study, we recorded single KATP channel currents using an inside-out patch clamp configuration and demonstrated that ketamine racemate and S-(+)-ketamine inhibited these channel activities induced by nicorandil in a concentrationdependent manner. Furthermore, the inhibitory effects of ketamine racemate had approximately 7-fold higher potency than those of S-(+)-ketamine. Since ketamine racemate is a mixture of S-(+) and R-(-)-ketamine stereoisomers, this observation would suggest that block of KATP channels by ketamine enantiomers may be at least partly stereoselective. Our results also demonstrated that intracellular MgADP restored the inhibitory action of ketamine racemate on nicorandil induced KATP channel activities.
KATP channels, which are widely distributed in many tissues, respond to alterations in the metabolic activity of the cell and thereby act as sensors of glucose and oxygen availability (1, 11) . In the cardiovascular system, the sarcolemmal KATP channels are present both in cardiomyocytes and vascular smooth muscle cells (1) . Recent physiological studies on mice lacking different KATP channel subunits have begun to clarify the roles of cardiac and vascular KATP channels in cardiovascular pathophysiology. Cardiac KATP channel (Kir6.2 -/ -)-deficient mice had a number of cardiac abnormalities during myocardial ischemia or severe stress, including impaired ischemic preconditioning and attenuated electrocardiographic ST changes (12) . Impaired vascular smooth muscle function was a feature of Kir6.1-deficient and SUR2-deficient mice and manifested as episodic coronary artery vasospasm and a high rate of sudden death (13, 14) . Nicorandil is a potent cardiac and vascular KATP channel opener (9) . In clinical practice, therefore, this drug is widely used in the treatment of ischemic heart disease (4). A recent study further suggested that prophylactic administration of nicorandil proved useful in the perioperative prevention of cardiac complications (5) .
Our previous study demonstrated that ketamine racemate directly inhibited sarcolemmal KATP channels that formed by subunits expressed in COS-7 cells (8) . The present study indicates that ketamine racemate also inhibits nicorandil induced KATP channel activities in native vascular smooth muscle cells (VSMCs). During surgical anaesthesia, clinical plasma concentrations for ketamine racemate are 20-50 μM, with approximately 12% of the drug being bound to plasma proteins (15) . In current study, the threshold concentrations of ketamine racemate which inhibits nicorandil induced KATP channel activities ("10 μM) are within this range, but the concentrations of S-(+)-ketamine required for inhibition were very high ("100 μM). It is likely, therefore, that ketamine racemate inhibits KATP channel activities induced by nicorandil at clinically relevant concentrations. These results suggested that ketamine racemate could impair nicorandil induced pharmacological organ-protection against intraoperative ischemic or hypoxic injury mediated by KATP channels. Indeed, racemic ketamine, but not the S-(+)-ketamine stereoisomer, was found to block early and late preconditioning in rabbit hearts (16, 17) and inhibit vasorelaxation induced by a KATP channel opener, levocromakalim (18) .
A previous study reported that acute ischemic preconditioning in the rabbit heart is observed with nicorandil treatment prior to ischemia, but not after myocardial ischemia (19) . These results indicate that activation of KATP channels during metabolic stress is essential for pharmacological organ protective effects of nicorandil.
During metabolic stress such as hypoxia or ischemia, the concentration of intracellular ADP rises while the levels of intracellular ATP drop. Similar to intracellular ATP, other magnesium nucleotides can modulate KATP channel activity, with the most dramatic effects being caused by MgADP, which antagonizes the inhibitory effects of ATP (1, 9) . Our recent electrophysiological results suggested that application of intracellular MgADP enhances the inhibitory effects of ketamine racemate on the activity of reconstituted KATP channels expressed in COS-7 cells (8) . We therefore hypothesised that intracellular MgADP also may enhance the inhibitory effects of ketamine racemate on nicorandil induced KATP channel activities. Surprisingly, our results demonstrated that the inhibitory effect of ketamine racemate at a clinically relevant concentration (30 μM) on nicorandil induced KATP channel activities was almost completely abolished by application of intracellular MgADP. These data suggest that the therapeutic effectiveness of nicorandil might not be impaired by ketamine racemate under metabolic stress conditions. The exact mechanisms of these effects have not been clearly identified. A recent study, however, indicated that metabolic inhibition significantly increased the potency of nicorandil on pig coronary artery relaxation (20) . These results suggest that MgADP may enhance nicorandil induced KATP channel activities. Thus, our results suggest that the MgADP enhancement of KATP channel activation of nicorandil could mask the inhibitory effects of ketamine racemate.
The inherent limitations of this study model must be addressed. First, the concentration of nicorandil we used in the current study (100 μM) should be much higher than the clinically relevant concentrations (approximately 1 μM) (21) . Therefore, it may be difficult to directly extrapolate our results to in vivo conditions. Second, we performed patch clamp experiments in cultured, not freshly isolated, VSMCs to avoid using damaged cells. Although cultured cells may undergo a variety of phenotypic changes, the functions of vascular KATP channels (e.g. sensitivity of KATP channel modulators and single channel conductance) were consistent with those of KATP channels previously recorded in freshly isolated VSMCs (22) .
In conclusion, our results demonstrated that ketamine inhibits nicorandil induced vascular KATP channels activity in a dose-dependent and stereoselective manner. However, our results further indicated that increase of intracellular MgADP markedly attenuated the inhibitory effect of ketamine. These results suggested the possibility that ketamine might not impair the beneficial vasodilative effects of nicorandil as a KATP channel opener under conditions of metabolic inhibition.
